Revision arthroplasty is required when a previous joint replacement (hip or knee) fails due to wear, infection, loosening, or instability. This complex surgery involves removing the old implant and using specialized revision components to restore joint stability and alleviate pain.
nStride Autologous Protein Solution (APS) is a non-surgical, "biologic" treatment that uses the patient's own blood to create a concentrated protein liquid. When injected into the knee, it blocks the inflammatory proteins responsible for cartilage breakdown, providing significant pain relief for up to a year.
ACL reconstruction restores stability to the knee after a ligament tear, preventing the "giving way" sensation. Using minimally invasive arthroscopic techniques, a graft is used to replace the torn ligament, allowing athletes and active individuals to return to sports safely.
The standards of joint replacement have by en large been dictated by Western research and literature that generally predict a specific body type and requirement for anatomical restoration. Modern day Asian surgeons who were trained in the West, however, realise that Asian patients are quite different. There is a tendency for increased femoral and tibial bowing and this results in unusual strains on implants designed for a Western individual. Furthermore, Asian patients tend to have a greater requirement for deep flexion for squatting.
Major links on the site of interest
Other links on the site of interest
The Foundation: Arthroplasty First Long before I specialized in oncology, I was a dedicated Arthroplasty Surgeon. I trained under the founding fathers of joint replacement in Singapore and rapidly mastered the craft. My proficiency wasn't just clinical; it was educational. I spent years as an International Trainer, conducting workshops and teaching the very techniques—like the Exeter Hip and soft-tissue balancing—that are now standard practice across the region.
The Logic of Transition: From "Replacement" to "Reconstruction" My transition to Musculoskeletal Oncology was not a departure from joint replacement; it was the ultimate evolution of it. After mastering the standard primary knee and hip replacement, the challenge shifted to the "impossible" cases: massive bone loss, pelvic discontinuities, and pediatric limb salvage.
A "Standard" Surgeon replaces a joint.
An Oncologist rebuilds the bone, the joint, and the surrounding soft tissues.
The Result: When I perform a standard knee replacement today, I am utilizing the same rigorous structural principles required to save a limb from cancer. It is "over-engineering" in the best possible way.
The Irony of "Overseas Training" It is a common trend for younger surgeons to boast of their prestigious fellowships in the UK, USA, or Australia. They claim to have trained under the "giants" of the industry. If you look closely at those "giants" in London, New York, or Sydney, you will find that nearly all of them are—like me—Musculoskeletal Oncologists. The global leaders in joint replacement are almost always tumor surgeons because only they possess the full spectrum of skills required to handle any complication.
The Bottom Line You can choose a surgeon who only knows how to do a standard replacement. Or, you can choose the surgeon who spent decades teaching others how to do them—and then moved on to master the cases they couldn't handle.